Equity · Token cap tables

Token warrants and side letters: how equity investors get token exposure.

Why shares in the company confer no claim on the token, how the two instruments differ, and the terms that actually get negotiated.

On this page

In short

What is a token warrant?

A token warrant is a right, granted alongside an equity investment, to acquire tokens if and when the project issues them. It exists because equity in an operating company is not a claim on a token issued by a different entity, so token exposure has to be granted by a separate instrument.

Granted with a SAFE or priced round · contingent on a token ever being issued

The problem the instrument exists to solve

Picture a typical structure. An operating company employs the engineers, owns the code and the trademarks, and raises a priced round or a SAFE from venture investors. A separate entity — commonly a foundation or association established offshore — issues the token, holds the treasury, and stewards the network. Both are part of the same project in every ordinary sense of the word.

Now ask what a preferred stockholder in the operating company owns. They own a residual claim on that company: its revenue, its assets, its eventual sale. They do not own the token, because the token was issued by a different legal person that they hold no interest in. If protocol value accrues to the token and the treasury rather than to the company’s income statement, an investor can be right about the project and still capture very little of it.

The token warrant and the token side letter are the market’s answer. They give the investor a contractual route to token exposure, negotiated at the same time as the equity, sized off the equity position, and documented separately because the thing being promised is issued by someone else. That separation is deliberate rather than sloppy — the reasons are set out in /equity/dual-cap-table.

Warrant or side letter

The two terms are used loosely and sometimes interchangeably, which is unhelpful because they behave differently at the moment tokens are issued. The distinction worth holding on to is whether the investor has to do something — pay, elect, exercise — or whether delivery simply happens.

Token warrant versus token side letter

Token warrant versus token side letter
FeatureToken warrantToken side letter
Nature of the rightAn option to acquire tokens — a right, not an obligationA right to receive tokens, typically without a separate election
Payment on the token sideUsually a nominal or discounted exercise price, paid at exerciseUsually none; the equity investment is treated as the consideration
What the investor decidesWhether to exercise, and when, within the exercise windowGenerally nothing — delivery follows the trigger
If the tokens are worth less than expectedThe investor can decline to exercise and walk awayThe investor receives them regardless, with whatever consequences follow
Where it usually attachesAlongside a priced round or a SAFE, as a standalone agreementAlongside a SAFE, as a letter amending or supplementing it
Practical effect if the project never launches a tokenExpires unexercisedNever triggers

Drafting varies widely and many agreements blend features of both. Read the operative clauses rather than relying on the document’s title.

The terms that get negotiated

The following are the clauses that consume the negotiation. Each is a genuine choice with consequences on the token register, and none has a settled market answer.

Commonly negotiated token warrant terms
TermWhat it decidesWhere the disagreement usually is
Allocation basisHow many tokens the right covers — most often the investor’s fully diluted equity percentage applied to a defined portion of token supplyWhich supply figure it applies to: total supply, the investor bucket, or supply net of the community allocation
Percentage snapshot dateWhether the equity percentage is measured at signing, at token generation, or at exerciseLater measurement exposes the investor to equity dilution; earlier measurement locks in a percentage that may no longer reflect their stake
Exercise priceWhat the investor pays on exercise — nominal, a fixed amount, or a discount to a launch priceWhether any price is charged at all, and how it is set if the token has no established price
Trigger eventWhat causes the right to become exercisable — token generation, network launch, listingDefinitional precision. "Token generation event" needs a definition that covers testnet tokens, points programmes, and multiple token launches
Exercise windowHow long the investor has to act after the triggerShort windows risk forfeiture; long ones leave a contingent claim hanging over supply indefinitely
Lock-up and unlock parityWhen delivered tokens actually become transferableInvestors want parity with the team; teams and foundations often want investor lock-ups at least as long as contributor ones
Coverage of future issuancesWhether the right extends to a second token, a fork, or a successor networkBroad coverage protects investors against restructuring; narrow coverage protects the project’s freedom to change direction
AssignabilityWhether the right can be transferred separately from the equityA freely assignable token right can end up held by someone the project never underwrote
Most-favoured-nation treatmentWhether better terms granted to a later investor flow backAlmost always contested, and the reason instrument coverage needs auditing before each round

The covenant chain, and why it is the real risk

Here is the structural weakness that gets least attention in template discussions. The document is usually signed by the operating company. The tokens will be issued by a different entity. A company cannot grant rights over property that belongs to someone else, so what the investor actually receives is generally a covenant: a promise by the company to procure that the issuer delivers, or to use defined efforts to bring it about.

Whether that covenant is worth anything depends on facts outside the four corners of the warrant. Does the company control the issuing entity? Is the issuer a party to the agreement, or bound by a back-to-back arrangement? What happens if the foundation’s council, exercising independent duties, declines? And note the awkward corner this sits in: the more tightly the company can compel the issuer, the less independent the issuer is — which cuts against the very separation the two-entity structure was built to achieve.

That is not a drafting nuisance; it is the same tension the SEC and CFTC described in their joint interpretation of 17 March 2026, which frames a crypto asset as becoming subject to an investment contract where an issuer’s representations or promises to undertake essential managerial efforts lead purchasers reasonably to expect profits, and as ceasing to be subject to one when purchasers can no longer reasonably view those promises as attached to the asset. A structure engineered to guarantee investors token upside from company effort is pulling in one direction; the analysis of the token’s own status pulls in the other.

How it lands on the two registers

A token warrant is easy to lose, because for most of its life it is not on either cap table in a visible way. It does not issue shares, so cap table software has nowhere to record it. It does not consume tokens until it is exercised, so the token register often carries it as a footnote or not at all. Then a token generation event happens and a set of contingent claims arrives at once.

  • On the company cap table: normally nothing. The warrant is over tokens, not shares, so it does not appear in the fully diluted share count and does not dilute other stockholders directly.
  • On the token cap table: a contingent claim against supply, which should be modelled in the investor bucket from the day it is signed rather than the day it is exercised.
  • In the company’s obligations: a covenant that may need disclosure in diligence, and that a later acquirer will certainly ask about.
  • In the reconciliation: a list of which investors hold one and which do not, maintained continuously — because the moment a new round opens, the ones who do not will want to know why.

The practical discipline is to model outstanding token warrants as if they were exercised, alongside the contributor and treasury buckets, so the token fully diluted figure is honest. That is the same reflex a good equity operator applies to an unexercised option pool, and it is described in the context of the whole register at /equity/token-cap-table.

Frequently asked questions

What is the difference between a token warrant and a token side letter?
A warrant is an option — the investor chooses whether to exercise, usually paying a nominal or discounted price. A side letter is closer to a promise to deliver tokens for no additional payment, with the equity investment treated as the consideration. Drafting frequently blurs the two.
How is the token allocation in a warrant calculated?
Most commonly by applying the investor’s fully diluted equity percentage to a defined slice of token supply. The negotiation is over which supply figure is used and at what date the percentage is measured, both of which materially change the answer.
Do token warrants dilute equity holders?
Not on the company cap table — they are rights over tokens, not shares. They consume token supply, which affects everyone on the token register. That asymmetry is a large part of why the two cap tables have to be read together.
What happens to a token warrant if the project never issues a token?
It expires unexercised. The investor keeps their equity position and receives nothing on the token side. Well-drafted warrants define the trigger and the longstop precisely so this outcome is unambiguous rather than argued about years later.
Is there a standard token warrant template?
No. Several publicly circulated templates are widely used and worth reading to understand the mechanics, but none has the quasi-standard status the SAFE achieved in conventional venture financing, and no regulator has endorsed any of them.
Should the warrant be signed by the company or the token issuer?
This is the central practical question and it depends on the structure. Where the company signs and a separate entity issues, the investor is relying on a covenant to procure delivery, and the strength of that covenant deserves as much scrutiny as the allocation maths.

Sources

External links open in a new tab.

  1. Application of the Federal Securities Laws to Certain Types of Crypto Assets and Certain Transactions Involving Crypto Assets (Rel. 33-11412; 34-105020, 17 March 2026)U.S. Securities and Exchange Commission, joined by the CFTCChecked 11 Aug 2026
  2. The SAFT Project: Toward a Compliant Token Sale Framework (October 2017)Cooley LLP and Protocol LabsBackground on the earlier instrument these structures largely displaced.Checked 11 Aug 2026
  3. Token warrant agreement template and guideLegal NodesA publicly available private drafting resource, cited to illustrate common mechanics. Not authority and not endorsed by any regulator.Checked 11 Aug 2026
  4. Token side letter templateLegal NodesAs above — a drafting resource, not authority.Checked 11 Aug 2026
  5. SEC v. W.J. Howey Co., 328 U.S. 293 (1946)Cornell Legal Information InstituteChecked 11 Aug 2026

Written by

Glide Research

Payments research

Glide Research maps payment rails, FX corridors, and banking access so travellers, freelancers, and treasury teams can move money without legacy wire tax.

Published

Glide · Equity

Token warrants and side letters: how equity investors get token exposure.

Why shares in the company confer no claim on the token, how the two instruments differ, and the terms that actually get negotiated.

Currencies
80+
Spend anywhere
Visa card
Regulated legs run by
Licensed partners